• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

CADx set to join mammography CAD race

Article

R2 Technology has had a corner on the FDA-approved computer-aided detection (CAD) technology market, but CADx Medical Systems is ready to jump in.CADx submitted the premarket approval application for its Second Look CAD technology in three parts. The

R2 Technology has had a corner on the FDA-approved computer-aided detection (CAD) technology market, but CADx Medical Systems is ready to jump in.

CADx submitted the premarket approval application for its Second Look CAD technology in three parts. The first component has already been approved. The second and third modules are slated to receive approval by the end of the year, according to CADx. n

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.